Ex-Sanofi chief Olivier Brandicourt, current Blackstone advisor, jumps on Alnylam board

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 28, 2020 at 11:02 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Former Sanofi chief Olivier Brandicourt, who departed his post with an unexpected early retirement last year, has made his move — as most C-suite executives inevitably do — to become a director on the board of a biopharma company.

    article source